Published on November 23, 2012 at 7:11 AM
CPhI's annual conference, Polymorphism 2012, is a two-day strategic meet taking place from 19-20 December at Hilton International Airport, Mumbai, India. This event has received a lot of interest from the pharma industry as it focuses on a very technical and important subject of polymorphism studies that poses challenges to this industry and excellence in this area is vital for this sector's continued growth.
Industry experts already confirmed to speak at the event include Rolf Hilfiker, Vice President, Solvias AG (Switzerland); Samir Haddouchi, Managing Director, SPS Pharma (France); Suresh Venkataram, Chief Scientific Officer, Semler Research Centre; Preetam Ghogale, Head Preformulations, Piramal Healthcare; Sharmistha Pal, Research Scientist I, Astra Zeneca amongst others.
This event will feature in-depth discussions on specific R&D, analytical, regulatory and IP challenges faced with respect to polymorphs. Understanding the importance and necessity of discussions, this event has a round table discussion with the experts. Queries related to polymorphism are invited from the industry participants and select queries will be discussed at this round table discussion forum. Visit www.polymorphism-india.com/pr to view the complete programme.
SOURCE UBM India Pvt. Ltd.